Vaccines
This groundbreaking diagnostic will combine Satio's patch-based blood collection device with Institut Pasteur de Dakar's sensitive and rapid...
August 21, 2023 | News
The collaboration between NOI and Nagasaki University aims to harness the power of advanced AI to optimize vaccine designs to be universally and broadly pr...
August 21, 2023 | News
First pneumococcal conjugate vaccine that fights against 20 serotypes leading to most of the invasive pneumococcal diseases and pneumonia[2],[3] &md...
August 11, 2023 | News
SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation and strengthen their strategic partnership. SK bioscien...
August 09, 2023 | News
Zuellig Pharma today announced that it has entered into an agreement with global biopharma company, GSK, to help set up its first vaccine distribution ...
August 01, 2023 | News
The Company proposes to adopt a randomized, double-blind, Shingrix® parallel controlled phase I clinical trial in 180 healthy adult subjects aged 40 an...
July 27, 2023 | News
Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri in the Asia Pacific region VBI will rece...
July 06, 2023 | News
Under the agreement, Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under Current Good Manufacturing Practice (CGMP) regulations to ...
July 06, 2023 | News
Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI in Greater China ...
July 06, 2023 | News
SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response platform, encompassing not only Thailand but extendi...
July 05, 2023 | News
SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the Peter Doherty Institute for Infection and Immunity...
June 27, 2023 | News
In a Phase III trial, the vaccine demonstrated neutralizing antibody responses against SARS-CoV-2 parental strain and had a standard safety and reactogen...
June 19, 2023 | News
Novavax has developed a protein-based monovalent XBB.1.5 COVID vaccine candidate and is manufacturing at commercial scale w...
June 16, 2023 | News
WestVac Biopharma and its subsidiary company WestVac Biopharma (Guangzhou) leveraged the rapid response of the insect cell expression platform on construct...
June 12, 2023 | News
Most Read
Bio Jobs
News
Editor Picks